Human Amyloid Precursor Protein (APP) CLIA Kit

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

amyloid-beta protein isoform a, Amyloid beta A4 protein, amyloid-beta precursor protein, amyloid beta precursor protein, ABPP, APPI, APP, Alzheimer disease amyloid protein, Cerebral vascular amyloid peptide, CVAP, PreA4, Protease nexin-II, PN-IICleaved into the following 14 chains:N-APPSoluble APP-alpha, S-APP-alphaSoluble APP-beta, S-APP-betaC99Beta-amyloid protein 42, Alternative name(s):, Beta-APP42Beta-amyloid protein 40, Alternative name(s):, Beta-APP40C83P3(42)P3(40)C80Gamma-secretase C-terminal fragment 59, Alternative name(s):, Amyloid intracellular domain 59, AICD-59, AID(59), Gamma-CTF(59)Gamma-secretase C-terminal fragment 57, Alternative name(s):, Amyloid intracellular domain 57, AICD-57, AID(57), Gamma-CTF(57)Gamma-secretase C-terminal fragment 50, Alternative name(s):, Amyloid intracellular domain 50, AICD-50, AID(50), Gamma-CTF(50)

APP; APP; AAA; AD1; PN2; ABPP; APPI; CVAP; ABETA; PN-II; preA4; CTFgamma; A4; AD1; APP; CVAP; PN-II; S-APP-alpha; S-APP-beta; AICD-59; AID(59); AICD-57; AID(57); AICD-50; AID(50)

4502167